hyperphosphatemia patients on hemodialysis
Showing 1 - 1 of 1
Hyperphosphatemia Patients on Hemodialysis Trial in Tokyo (TS-172 10mg bid, TS-172 30mg bid, TS-172 60mg bid)
Not yet recruiting
- Hyperphosphatemia Patients on Hemodialysis
- TS-172 10mg bid
- +4 more
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Jan 23, 2023